Vascular Stent Market

Global Vascular Stent Market Size

The global vascular stent market was valued at USD 18.91 billion in 2024. The size of the global vascular stent market is predicted to be worth USD 38.11 billion by 2033 and USD 20.44 billion in 2025, growing at a CAGR of 8.10% during the forecast period.

In the present time, the vascular stent market is rapidly gaining traction and is witnessing greater focus on the research and development projects. Moreover, cardiovascular disease (CVD) has become a significant global health concern even when the death due to this has gone down in contrast to the period before the provision or accessibility of PCI procedure. In addition, today, treatment of CAD encompasses both coronary artery graft (CABG) and percutaneous coronary intervention (PCI) surgery.

The market saw the Biodegradable stents (BDS) arising as a viable substitute for traditional bare metal stents (BMS) and drug-eluting stents (DES). Since BDS can be engulfed and separated by the human body after a specific time, it displays a reduced rate of incidence for adverse impacts like late ST and ISR.

The presence of some of the quickly aging countries, South Korea, Japan, etc., makes the Asia Pacific region a lucrative market as a whole. Likewise, the prevalence of vascular diseases among the elderly people in South Korea (SK) is increasing because the country is getting nearing to the status of a super-aged society. This surges the significance of therapeutic stents. Not long ago, in 2024, the SK’s Minister of the Interior and Safety publicly announced that their country has transformed into a “super-aged” society since the portion of the country’s population aged 65 or older than running at 20 per cent.

China is another nation grappled by this trend. The state did and continues to implement a range of strategies to tackle the demographic crisis by introducing incentives like longer maternity leave, tax breaks, giving cash payments for 2^nd or 3^rd children in a few cities, etc. Similarly, Japan is dealing with a low birth rate and longevity. The island nation is the second biggest ageing population. It is at a critical juncture regarding its societal functionality. Furthermore, Italy is next in line to suffer from this phenomenon. Nearly one-fourth of its population is more than the age of 65 years old, as per data, placing it 4^th among the most ageing communities in the world.

MARKET DRIVERS

The growing patient population suffering from cardiovascular and obesity problems worldwide, and the increasing aging population are primarily fuelling the growth of the global vascular stent market.

Adopting sedentary lifestyles and changes in food habits also affect the growth rate of the global vascular stent market. Increasing capital income in both developed and developing countries sets up growth opportunities for the market. People's priority for minimally invasive surgeries is surging the growth of the market to the extent. Furthermore, growing concern about health and demand for proper treatment procedures prompts the need for the vascular stent market. Major companies manufacturing vascular stent devices are involved in strategic acquisitions, collaborations, and mergers to sustain the market. As there is a significant rise in the number of patients suffering from cardiovascular diseases, the medical field companies focus on innovations and new medical concepts to increase the recovery rate of treatments.

MARKET RESTRAINTS

Limitations of biodegradable stents are impeding the growth of the vascular stent market. Regardless of their ability, these stents many times show restricted mechanical strength in contrast to their metal counterparts, which could result in stent malfunction or structural collapse. Furthermore, their inconsistent degradation rates may not fully match with issue recovery processes, possibly leading to premature deterioration or insufficient support, hindering the market growth. In addition, inflammatory reactions to the by-products of decaying can take place. This results in the irritation of the tissue or adverse outcomes.

Additionally, market players are trying to attain fine or accurate control across degradation kinetics, yet it continues to be challenging, obstructing patient safety and perfect clinical results. The application of joint polymers, like  PCL-PLA, in stents assists in mitigating pain to a certain degree, but it falls short in resolving all the fundamental problems. All these aspects have a major negative effect on the market growth.

Drawbacks related to the shape memory polymers (SMPs) also restrict the market expansion. Like BDSs, SMPs demonstrate reduced stiffness and greater flexibility compared to traditional metal ones, which may curb their use in situations needing strong structural reinforcement. Also, SMP stents similar to metallic equivalents can pose thrombogenicity difficulties, compelling cautious selection of material and surface changes to improve blood compatibility. Ultimately, the lasting constancy and its durability under repetitive loading and corrosive conditions in bodily fluids call for detailed investigation and optimization.

REPORT COVERAGE

REGIONAL ANALYSIS

By Product Insights

Based on the product, Coronary stents product type is dominating with the highest shares of the market. Focusing on promoting the well-being of the patient after surgery with less pain is enhancing the market demand. In addition, increasing disposable income in urban areas is fuelling the growth of the market. Moreover, new-generation drug-eluting stents (DES) also influence the segment’s market share and are designed with novel metallic alloys that support thinner strut platforms and incorporate improved drug-eluting barriers. This leads to enhanced effectiveness in preventing restenosis.

By Type Insights

Based on type, the Drug-eluting stents type holds the highest shares of the market. Increasing the scale of pharmaceutical industries and growing priority to manufacture quality drugs at low cost are prompting the market demand. Besides this, consistent development and study to improve all facets of DES technology, like antiproliferative drugs, additional coating, polymers, coating distribution, and platform material and structure, have resulted in a novel, enhanced generation of this stent type. Ultimately, expanding the segment’s market size.

By Mode of Delivery Insights

Based on the Mode of Delivery, Balloon's expandable stents mode of delivery has been growing faster in recent years. In addition, a rise in awareness of the availability of various treatment procedures through digital advertisements boosts the market demand. However, the limitations of balloons have once driven the rise of self-expanding stents. Likewise, Endoscopic ultrasound (EUS)-guided interventions have swiftly matured in the last few years for the administration of several pancreatobiliary diseases, with devoted stents performing an important part in this procedure.

By Material Insights

Based on the material, the metallic stents segment is predicted to hold a significant share of the worldwide market. In addition, a rise in the demand for long-span materials magnifies the market's growth rate. However, in recent years, a new generation of DES has quickly become popular and is built of new metallic alloys, like platinum-chromium and cobalt-chromium. These features reduced stent strut thickness, i.e., 50 to 90 um, and at the same time, still maintained sufficient radial strength.

By End-user Insights

Based on End-User, the hospital segment held the largest share of the worldwide market in 2023. The emergence of the latest equipment in hospitals with support from private and public organizations is broadening the market's growth. Also, a rise in the flow of patients to hospitals is leveraging the demand for this segment. Presently, the practice of coronary angioplasty with the addition of stents is more widely adopted compared to angioplasty alone.

REGIONAL ANALYSIS

Based on region, the vascular stent market in North America is leading, accounting for a significant global market share, with the United States accounting for a considerable percentage. North America's lead is warranted by the presence of a high incidence of CVD patients and the increasing use of vascular stents by cardiovascular surgeons. On the other hand, Europe comes in second in market share due to rising awareness about blood-related disorders and the swift availability of treatment in terms of plasma fractionation. Further, increasing investments in the construction of hospitals are elevating the demand for this market. Also, ongoing research in developing new products with the help of advanced technology is significantly influencing the need for the vascular stent market.

The vascular stent market in Europe is predicted to grow faster in the foreseeable years, with growing revenue strength in significant countries. Also, increasing incidences of various diseases related to the heart boost the growth of the market.

The vascular stent market in the Asia-Pacific region is expected to expand at the highest CAGR during the forecast period. It is due to the presence of a vast population base, increasing adoption of advanced technologies, and the low manufacturing costs of Vascular Stents in the emerging economies of the region.

The growth of the  Vascular Stent Market in Latin America is driven by factors such as the increasing geriatric populace, the growing frequency of incidence of cardiovascular diseases, and the rising consumer and surgeon preference for stents in place of substantially invasive procedures.

The growth of the Vascular Stent Market in the Middle East & Africa is driven by the increasing use of vascular stents for cardiovascular diseases. This is further supplemented by the increasing preference for stents over other outdated methods, which were relatively more invasive. The rising elderly populace in the Middle East and Africa, with the consequently increasing incidence of CVD, is also a major driver of market growth in the region.

KEY MARKET PARTICIPANTS

Noteworthy companies operating in the global vascular stent market profiled in this report are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG, B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).

RECENT MARKET DEVELOPMENTS

• In June 2024, a research group under the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with an expert from KIST Euro, reported the creation of a unique stent surface treatment technology through laser patterning. With this development, the market is expected to achieve further expansion in the coming years. In Addition, this technology encourages the growth of the endothelial cell alongside preventing the dedifferentiation of smooth muscle cells in vascular tissues. The approach offers hope for improving vascular recovery, particularly when coupled with chemical coating techniques.
• In February 2019, Biotronik received approval from the United States FDA for tits itsorisio drug-eluting stent, an ultrathin and bioresorbable stent. This new product is intended for PCI (Percutaneous coronary intervention) procedures. It has made the company explore its business, strengthen its market among competitors, and expand its existing customer base.
• In November 2018, WL Gore and associates received approval from the United States FDA for their new product, the goGore Carotid Stentwhich will be used to reopen the narrowed carotid arteries responsible for supplying blood to the brain. These innovations have strengthened its market growth among other vascular stent companies in the United States of America.

MARKET SEGMENTATION

This research report on the global vascular stent market has been segmented and sub-segmented based on the product, type, mode of delivery, material, end-user, and region.

By Product   

• Coronary Stents
• Peripheral Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Femoral Artery Stents
  • Iliac Artery Stents
  • Other Peripheral Stents
• EVAR Stent Grafts
  • Abdominal Aortic Aneurysm Stents
  • Thoracic Aortic Aneurysm Stents

By Type

• Drug-Eluting Stents
• Bare Metal Stents   
• Bioabsorbable Stents

By Mode of Delivery

• Balloon Expandable Stents 
• Self-Expanding Stents

By Material

• Metallic Stents
• Cobalt-Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Polymer Stents
• Other materials

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa